Comparative efficacy and safety of novel immuno-chemotherapy for extensive-stage small-cell lung cancer: a network meta-analysis of randomized controlled trial

BACKGROUND: Recently, several new first-line immune checkpoint inhibitors (ICIs) plus chemotherapy have been approved for patients with extensive-stage small-cell lung cancer (ES-SCLC). However, direct comparisons between first-line treatments are lacking. Therefore, we indirectly compared the effic...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Youwen, Liu, Kun, Zhu, Hong, Cao, Hui, Zhou, Yangying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Controversies in Immunotherapy for Patients with Lung Cancer: Pragmatic Solutions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576922/
https://www.ncbi.nlm.nih.gov/pubmed/37846397
http://dx.doi.org/10.1177/17588359231206147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576922/
https://www.ncbi.nlm.nih.gov/pubmed/37846397
http://dx.doi.org/10.1177/17588359231206147

Ejemplares similares